Gynecomastia: pathomechanisms and treatment strategies
- PMID: 11546925
- DOI: 10.1159/000185497
Gynecomastia: pathomechanisms and treatment strategies
Abstract
Gynecomastia is common in adolescents and adults, and reflects an underlying imbalance in hormonal physiology in which there is an increase in estrogen action relative to androgen action at the breast tissue level. Most patients have persistent pubertal gynecomastia or breast glandular enlargement from medications, age-related reduction in testicular function, or idiopathic causes. Gynecomastia must be differentiated from pseudogynecomastia due to increased breast adipose tissue, as well as from breast carcinoma. The evaluation of the causes of gynecomastia can be accomplished through history, physical examination and a few laboratory tests. Painful gynecomastia of recent onset may respond to antiestrogen therapy. Surgical removal is the mainstay for long-standing gynecomastia or glandular enlargement that is unresponsive to medical therapy.
Similar articles
-
EAA clinical practice guidelines-gynecomastia evaluation and management.Andrology. 2019 Nov;7(6):778-793. doi: 10.1111/andr.12636. Epub 2019 May 16. Andrology. 2019. PMID: 31099174
-
[Evaluation and management of gynecomastia].Rev Med Suisse. 2009 Apr 8;5(198):783-7. Rev Med Suisse. 2009. PMID: 19418981 French.
-
[Disordered hormone regulation in gynecomastia].Kongressbd Dtsch Ges Chir Kongr. 2002;119:743-7. Kongressbd Dtsch Ges Chir Kongr. 2002. PMID: 12704923 German.
-
Pubertal gynecomastia.J Pediatr Endocrinol Metab. 2002 May;15(5):553-60. doi: 10.1515/jpem.2002.15.5.553. J Pediatr Endocrinol Metab. 2002. PMID: 12014513 Review.
-
Gynecomastia in adolescents.Curr Opin Pediatr. 2008 Aug;20(4):375-82. doi: 10.1097/MOP.0b013e328306a07c. Curr Opin Pediatr. 2008. PMID: 18622190 Review.
Cited by
-
Gynecomastia: pathophysiology, evaluation, and management.Mayo Clin Proc. 2009 Nov;84(11):1010-5. doi: 10.1016/S0025-6196(11)60671-X. Mayo Clin Proc. 2009. PMID: 19880691 Free PMC article. Review.
-
Radiation therapy for the treatment of benign vascular, skeletal and soft tissue diseases.Clin Transl Oncol. 2008 Jun;10(6):334-46. doi: 10.1007/s12094-008-0209-6. Clin Transl Oncol. 2008. PMID: 18558580 Review.
-
Gynecomastia and hormones.Endocrine. 2017 Jan;55(1):37-44. doi: 10.1007/s12020-016-0975-9. Epub 2016 May 4. Endocrine. 2017. PMID: 27145756 Review.
-
Partial Androgen Insensitivity Syndrome Presenting with Gynecomastia.Endocrinol Metab (Seoul). 2015 Jun;30(2):226-30. doi: 10.3803/EnM.2015.30.2.226. Epub 2014 Nov 26. Endocrinol Metab (Seoul). 2015. PMID: 25433660 Free PMC article.
-
Correlation between gynecomastia and endocrine regulation in patients with metabolic dysfunction-associated fatty liver disease: A cross-sectional study.World J Hepatol. 2025 Jun 27;17(6):108096. doi: 10.4254/wjh.v17.i6.108096. World J Hepatol. 2025. PMID: 40606934 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources